Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Kenneth R. Hess

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1377-6070; OpenAlex author ID A5005194857. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2011: 4 papers · 2012: 2 papers · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper

Papers 9

  1. Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older. Co-author DOI 10.1016/j.pan.2020.01.005↗
  2. Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience. Co-author DOI 10.18632/oncotarget.19897↗
  3. New option for the initial management of metastatic pancreatic cancer? First author DOI 10.1200/jco.2013.54.4155↗
  4. DNA mismatch repair network gene polymorphism as a susceptibility factor for pancreatic cancer. Co-author DOI 10.1002/mc.20817↗
  5. Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer. Co-author DOI 10.1016/j.canep.2011.05.013↗
  6. Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer. Co-author DOI 10.1002/cncr.25612↗
  7. A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer. Co-author DOI 10.1007/s10637-010-9386-6↗
  8. Glucose metabolism gene variants modulate the risk of pancreatic cancer. Co-author DOI 10.1158/1940-6207.capr-10-0247↗
  9. DNA mismatch repair gene polymorphisms affect survival in pancreatic cancer. Co-author DOI 10.1634/theoncologist.2010-0127↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. James L. Abbruzzese · 7 shared papers, 2011–2014 · strength 0.28
  2. Milind M. Javle · 3 shared papers, 2011–2020 · strength 0.18
  3. Robert A. Wolff · 3 shared papers, 2011–2020 · strength 0.18
  4. Gauri Rajani Varadhachary · 3 shared papers, 2011–2020 · strength 0.18
  5. Xiaoqun Dong · 5 shared papers, 2011–2012 · strength 0.17
  6. Donghui Li · 5 shared papers, 2011–2012 · strength 0.17
  7. David R. Fogelman · 2 shared papers, 2017–2020 · strength 0.16
  8. Michael James Overman · 1 shared paper, 2020 · strength 0.10
  9. Rachna T. Shroff · 1 shared paper, 2020 · strength 0.10
  10. Jonathan D. Mizrahi · 1 shared paper, 2020 · strength 0.10
  11. Jane Elizabeth Rogers · 1 shared paper, 2020 · strength 0.10
  12. Shubham Pant · 1 shared paper, 2020 · strength 0.10
  13. Linus Ho · 1 shared paper, 2020 · strength 0.10
  14. Kanwal P. S. Raghav · 1 shared paper, 2020 · strength 0.10
  15. Ping Chang · 3 shared papers, 2011–2012 · strength 0.10
  16. Hongwei Tang · 3 shared papers, 2011–2012 · strength 0.10
  17. Funda Meric-Bernstam · 1 shared paper, 2017 · strength 0.05
  18. Sarina Anne Piha-Paul · 1 shared paper, 2017 · strength 0.05
  19. Jennifer Brooke Goldstein · 1 shared paper, 2017 · strength 0.05
  20. Chad Z. Tang · 1 shared paper, 2017 · strength 0.05
  21. Apostolia Maria Tsimberidou · 1 shared paper, 2017 · strength 0.05
  22. Vivek Subbiah · 1 shared paper, 2017 · strength 0.05
  23. David S. Hong · 1 shared paper, 2017 · strength 0.05
  24. Aung Naing Pe · 1 shared paper, 2017 · strength 0.05
  25. Siqing Fu · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.